ELVN logo

Enliven Therapeutics, Inc. (ELVN) Current liabilities

annual current liabilities:

$15.91M-$9.98M(-38.54%)
December 31, 2024

Summary

  • As of today (July 11, 2025), ELVN annual total current liabilities is $15.91 million, with the most recent change of -$9.98 million (-38.54%) on December 31, 2024.
  • During the last 3 years, ELVN annual current liabilities has risen by +$10.16 million (+176.64%).
  • ELVN annual current liabilities is now -38.54% below its all-time high of $25.89 million, reached on December 31, 2023.

Performance

ELVN Current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNbalance sheet metrics

quarterly current liabilities:

$13.97M-$1.94M(-12.21%)
March 31, 2025

Summary

  • As of today (July 11, 2025), ELVN quarterly total current liabilities is $13.97 million, with the most recent change of -$1.94 million (-12.21%) on March 31, 2025.
  • Over the past year, ELVN quarterly current liabilities has dropped by -$11.06 million (-44.18%).
  • ELVN quarterly current liabilities is now -46.04% below its all-time high of $25.89 million, reached on December 31, 2023.

Performance

ELVN quarterly current liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherELVNbalance sheet metrics

Current liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

ELVN Current liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-38.5%-44.2%
3 y3 years+176.6%-
5 y5 years+976.8%+142.9%

ELVN Current liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-38.5%+176.6%-46.0%+67.7%
5 y5-year-38.5%+976.8%-46.0%+142.9%
alltimeall time-38.5%+976.8%-46.0%+142.9%

ELVN Current liabilities History

DateAnnualQuarterly
Mar 2025
-
$13.97M(-12.2%)
Dec 2024
$15.91M(-38.5%)
$15.91M(-6.5%)
Sep 2024
-
$17.03M(-23.0%)
Jun 2024
-
$22.11M(-11.7%)
Mar 2024
-
$25.03M(-3.3%)
Dec 2023
$25.89M
$25.89M(+114.4%)
Sep 2023
-
$12.08M(+32.1%)
DateAnnualQuarterly
Jun 2023
-
$9.15M(-16.4%)
Mar 2023
-
$10.94M(+12.6%)
Dec 2022
$9.71M(+68.9%)
$9.71M(+16.6%)
Sep 2022
-
$8.33M(+44.8%)
Dec 2021
$5.75M(+289.2%)
-
Dec 2021
-
$5.75M
Dec 2020
$1.48M
-

FAQ

  • What is Enliven Therapeutics, Inc. annual total current liabilities?
  • What is the all time high annual current liabilities for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. annual current liabilities year-on-year change?
  • What is Enliven Therapeutics, Inc. quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Enliven Therapeutics, Inc.?
  • What is Enliven Therapeutics, Inc. quarterly current liabilities year-on-year change?

What is Enliven Therapeutics, Inc. annual total current liabilities?

The current annual current liabilities of ELVN is $15.91M

What is the all time high annual current liabilities for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high annual total current liabilities is $25.89M

What is Enliven Therapeutics, Inc. annual current liabilities year-on-year change?

Over the past year, ELVN annual total current liabilities has changed by -$9.98M (-38.54%)

What is Enliven Therapeutics, Inc. quarterly total current liabilities?

The current quarterly current liabilities of ELVN is $13.97M

What is the all time high quarterly current liabilities for Enliven Therapeutics, Inc.?

Enliven Therapeutics, Inc. all-time high quarterly total current liabilities is $25.89M

What is Enliven Therapeutics, Inc. quarterly current liabilities year-on-year change?

Over the past year, ELVN quarterly total current liabilities has changed by -$11.06M (-44.18%)
On this page